After a successful proof-of-concept study in 2017, Genomenon is well into its work under a two-year, $1.5 million National Institutes of Health grant to add artificial intelligence to variant interpretation. Continue Reading….
July 31, 2018 – Genomenon in Ann Arbor Awarded NIH Grant to Further Scale the Adoption of Genomic Sequencing
Ann Arbor-based Genomenon, a leading genomic data search company that operates the world’s only comprehensive genomic-specific search engine, today announced it was awarded a Phase 2 Small Business Innovation Research (SBIR) grant by the National Institutes of Health (NIH). Continue Reading….
Genomic Data Search company Genomenon has been awarded a Phase 2 Small Business Innovation Research grant by the National Institutes of Health. The grant will be used to develop and apply machine learning and artificial intelligence algorithms to variant interpretation, the single biggest hurdle in scaling the adoption of genomic sequencing in both clinical and precision medicine applications. Continue Reading….
Collaborations have long produced some of the most significant developments and discoveries in science, art and engineering. It’s not just people either. Huge benefits can come from businesses doing the same. I’ve taken a look at 5 collaborations that are doing just that. Continue Reading….
The Ann Arbor, MI, startup focused on analyzing genomics data to guide clinicians in the diagnostic process, last week announced its newest partnership. The company has entered into a co-marketing agreement with San Francisco’s Fluidigm, which develops, manufactures, and markets analytical systems with life sciences applications. Continue Reading….
The companies have signed a co-marketing agreement to create a joint panel design offering intended to help researchers accelerate the design of disease-specific next-generation sequencing (NGS), genotyping, and real-time PCR panels for use with Fluidigm’s automated microfluidic systems. Continue Reading….
Joint offering enables acceleration of genomic panel design for translational and clinical disease research Joint offering enables acceleration of genomic panel design for translational and clinical disease research. Continue Reading….
Fluidigm Corporation announced today that it has entered into a co-marketing agreement with Genomenon to offer evidence-based genomic panel design services for translational and clinical disease research. Continue Reading….
Fluidigm has announced that it has entered a co-marketing agreement with Genomenon to offer evidence-based genomic panel design services for translational and clinical disease researchers. Continue Reading….
Swift Biosciences and Genomenon said today that they have entered a new partnership in which they will co-market a service for the design and creation of targeted gene sequencing panels. Continue Reading….
May 22, 2018 – Learning the Literature: Genomenon, Veritas Collaborate on Next-Gen Publication Prioritization Engine
Genomenon has announced it will partner with Veritas Genetics to develop a next-generation literature prioritization engine the companies said will further scale the global adoption of whole-genome sequencing by reducing the time and cost of variant interpretation. Continue Reading….
Apr 26, 2018 – Ann Arbor’s Genomenon, a startup focused on genomic search data, has struck a new partnership with Boston’s Rhythm Pharmaceuticals
Genomenon and Rhythm will team up to create a database of genetic mutations associated with obesity as documented in the medical literature. Genomenon has developed Mastermind, a genomic search engine that connects genomic data with evidence from scientific literature. Continue Reading….
Genomenon said today it has partnered with Rhythm Pharmaceuticals to create a database of genetic mutations associated with obesity as documented in published studies. Rhythm plans to use the data to better understand rare genetic disorders of obesity. Continue Reading….
Genomenon announced Mastermind Genomic Search Engine users can accelerate their genomic interpretation by searching the scientific literature that fits each individual ACMG classification criteria. Continue Reading….
Genomenon will partner with Veritas, The Genome Company, to develop a next-generation literature prioritization engine designed to further scale the global adoption of whole genome sequencing by reducing the time and cost of variant interpretation. Continue Reading….
DNA sequencing company Veritas Genetics is partnering with genomic literature search engine Genomenon in an effort to move literature prioritization forward with the help of artificial intelligence. Continue Reading….
GenomeNext has embedded within its Olympus genomic analysis platform results from Genomenon’s Mastermind Genomic Search Engine, through a partnership aimed at accelerating variant curation for genomic analysis. Continue Reading….
Integrating Mastermind with GenomeNext’s Olympus Platform dramatically improves and accelerates variant curation, further streamlining automation of genomic analysis and interpretation. Continue Reading….
Genomenon’s Mastermind genomic search engine now includes links to Saphetor’s VarSome genomic annotation tool. In turn, VarSome, which contains curated data from more than 30 publicly available genomic databases, has Mastermind links to scientific literature related to each variant and gene. Continue Reading….
Jan 1, 2018 – Genomenon Illuminates Current Trends in Genomic Literature – Top 10 Cited Variants in 2017
Mastermind Genomic Search Engine Dives into Current Trends in Genomic Variant Research – A Look at the Top Cited Variants Across the Scientific Literature. Continue Reading….
Genomenon, a University of Michigan spinout developing analytics and data visualization software for the genomics industry, last week announced it has created an evidence-based cancer gene panel using automated machine learning techniques. Continue Reading….
Dr. Mark Kiel, MD PhD, Founder and Chief Scientific Officer of Genomenon Shares His Views on Diagnostic Genomics in Risk Roundup Interview. Continue Reading….
Genomenon, developing analytics and data visualization software for the genomics industry, released its first product last week: The Mastermind Genomic Search Engine. Continue Reading….
Mike Klein, a veteran of the Ann Arbor tech scene, was named CEO of Genomenon, a spinoff from the University of Michigan that creates genome interpretation software to speed patient diagnosis using personalized medicine. Continue Reading….
The University of Michigan’s Monroe-Brown Biomedical Seed Fund announced inaugural investments in two biotech startups spun out of the university. Continue Reading….
Like a lot of tech startups, Ann Arbor-based Genomenon has a name that’s a little hard to say and a suite of products that’s hard for non-techies to understand. What’s clear is Genomenon’s … Continue Reading….
NEW YORK (GenomeWeb) – Genomenon, an Ann, Arbor, Michigan-based startup focused on developing tools for the personalized medicine space, is currently recruiting early adopters to test-drive … Continue Reading….
When Steve Schwartz went up to collect the ceremonial $100,000 check for taking second place at the Accelerate Michigan Innovation Competition last week, he was surprised but not shocked. Continue Reading….
Genomenon Inc., a University of Michigan spinoff that is being incubated in the office of technology transfer’s Venture Accelerator on the north campus, has closed an investment round of $1 million. Continue Reading….
Each of the Healthcare finalists presented their ideas to a panel of expert judges for a chance to win $1 million and work with Verizon to turn their idea into a reality. Continue Reading….
Three U-M pathologists who developed software that could improve cancer diagnosis and treatment have won a statewide entrepreneurship competition … Continue Reading….